<?xml version="1.0" encoding="UTF-8"?>
<ref id="B210-ijms-21-05559">
 <label>210.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Rademaker</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Baker</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Foley</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement</article-title>
  <source>Austral. J. Dermatol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1111/ajd.13313</pub-id>
 </element-citation>
</ref>
